The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization The FDA's Current Position on Peptides Explained Holt Law BPC 157: Miracle Healing Peptide or Hidden Danger? FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC